title: Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
abstract: Amorphous solid dispersions have great potential for enhancing oral absorption of poorly soluble drugs. Crystallization behavior during storage and after exposure to aqueous media must be examined in detail for designing stable and effective amorphous formulations, and it is significantly affected by the intrinsic properties of an amorphous drug. Many attempts have been made to correlate various thermodynamic parameters of pharmaceutical glasses with their crystallization behavior; however, variations in model drugs that could be used for such investigation has been limited because the amorphous characteristics of drugs possessing a high crystallization tendency are difficult to evaluate. In this study, high-speed differential scanning calorimetry, which could inhibit their crystallization using high cooling rates up to 2000°C/s, was employed for assessing such drugs. The thermodynamic parameters of the glasses, including glass transition temperature (T(g)) and fragility, were obtained to show that their crystallization tendency cannot be explained simply by the parameters, although there have been general thought that fragility may be correlated with crystallization tendency. Also investigated was correlation between the thermodynamic parameters and crystallization tendency upon contact with water, which influences in vivo efficacy of amorphous formulations. T(g) was correlated well with the crystallization tendency upon contact with water.
authors.affiliation: International Center for Materials Nanoarchitectonics (WPI-MANA), National Institute for Materials Science, Tsukuba, Ibaraki 305-0044, Japan. kawakami.kohsaku@nims.go.jp
authors.forename: Kohsaku
authors.initials: K
authors.lastname: Kawakami
authors.forename: Toshinori
authors.initials: T
authors.lastname: Usui
authors.forename: Mitsunari
authors.initials: M
authors.lastname: Hattori
mesh_terms: D002152:Calorimetry, Differential Scanning; D002626:Chemistry, Pharmaceutical; D003460:Crystallization; D004304:Dosage Forms; D004355:Drug Stability; D006860:Hydrogen Bonding; D008956:Models, Chemical; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012997:Solvents / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods; D044366:Transition Temperature; D014867:Water / Q000737:chemistry
chemical_list: D004304:Dosage Forms; D004364:Pharmaceutical Preparations; D012997:Solvents; D014867:Water